Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate

Serum-free cell culture: the serum-free media interactive online database

(2016) Daniel Brunner   ALTEX-Alternatives to Animal Experimentation

Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?

(2015) Brooke Farrugia et al.   MOLECULES

Heparin induced thrombocytopenia

(2015) L.-A. Linkins   BMJ-British Medical Journal

Heparin induced thrombocytopenia

(2015) L.-A. Linkins   BMJ-British Medical Journal

Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation

(2014) A. Reinisch et al.   BLOOD

The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates

(2014) Julie Kaiser-Guignard et al.   BLOOD REVIEWS

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions

(2014) Sara Castiglia et al.   CYTOTHERAPY

Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells

(2014) Hatim Hemeda et al.   CYTOTHERAPY

Proteome Changes in Platelets After Pathogen Inactivation—An Interlaboratory Consensus

(2014) Michel Prudent et al.   TRANSFUSION MEDICINE REVIEWS

Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products

(2014) James Gombold et al.   VACCINE

Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy

(2014) Justin D Glenn   World Journal of Stem Cells

The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy

(2013) Ian B. Copland et al.   BIOMATERIALS

Functional and differential proteomic analyses to identify platelet derived factors affecting ex vivo expansion of mesenchymal stromal cells

(2013) Sven Kinzebach et al.   BMC CELL BIOLOGY

A plea to reduce or replace fetal bovine serum in cell culture media

(2013) Gerhard Gstraunthaler et al.   CYTOTECHNOLOGY

Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures

(2013) Mariluz P. Mojica-Henshaw et al.   CYTOTHERAPY

Heparin concentration is critical for cell culture with human platelet lysate

(2013) Hatim Hemeda et al.   CYTOTHERAPY

Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling

(2013) Rokhsareh Rohban et al.   PLoS One

Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms

(2012) S. Otsuru et al.   BLOOD

Heparin Disrupts the CXCR4/SDF-1 Axis and Impairs the Functional Capacity of Bone Marrow–Derived Mononuclear Cells Used for Cardiovascular Repair

(2012) Florian H. Seeger et al.   CIRCULATION RESEARCH

FGF9 and FGF20 Maintain the Stemness of Nephron Progenitors in Mice and Man

(2012) Hila Barak et al.   DEVELOPMENTAL CELL

Clinical applications of mesenchymal stem cells

(2012) Shihua Wang et al.   Journal of Hematology & Oncology

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

(2012) Peter Connick et al.   LANCET NEUROLOGY

Species-specific identification of ruminant components contaminating industrial crude porcine heparin using real-time fluorescent qualitative and quantitative PCR

(2011) Qing Huang et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Methods to select suitable fetal bovine serum for use in quality control assays for the detection of adventitious viruses from biological products

(2011) Takashi Kozasa et al.   BIOLOGICALS

Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials

(2011) C. R. Almeida et al.   Journal of the Royal Society Interface

Phototherapy in the Age of Biologics

(2011) Daniel Walker et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lessons learned from the contamination of heparin

(2009) Haiying Liu et al.   NATURAL PRODUCT REPORTS

Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow

(2009) Karen Bieback et al.   STEM CELLS

Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs)

(2009) Andreas Reinisch et al.   Jove-Journal of Visualized Experiments

Rheology

(2008) Paul A. Janmey et al.   CURRENT BIOLOGY

From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?

(2008) Gaetana A. Tonti et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Outbreak of Adverse Reactions Associated with Contaminated Heparin

(2008) David B. Blossom et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Large-Scale Expansion of Functional Mesenchymal Stem Cells from Unmanipulated Bone Marrow Without Animal Serum

(2008) Katharina Schallmoser et al.   TISSUE ENGINEERING PART C-METHODS